Although the immune response in CeD is mainly Th1, an increase in the secretion of the Th2 cytokine IL-13 has been reported in refractory CeD, and this mechanism could be important in maintaining the villous damage [53]. The gene discussed is IL13; the disease is cranioectodermal dysplasia.